Clinical trial INCB59872-101
A Phase 1/2, Open-Label, Dose-Escalation / Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced Malignancies
Cancers | |
---|---|
Organ | Solid tumors |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/2 |
Academic trial | Non |
Sponsor | Incyte Corporate |
EudraCT Identifier | 2017-001710-28 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02712905 |
Inclusion criteria | Any line |
Last update |